๐ฐ Genomic Diagnostics News
Page 2 - Genomic Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genomic Diagnostics. Real-time updates on events, politics, business and more.
February 1, 2022
Fusion oncogenes, such as RET- and NTRK-gene fusions, are associated with more invasive pediatric thyroid cancers, correlating with the highest risk of metastases and a lower likelihood of achieving remission one year after initial therapy, according to a new study by researchers at Children's Hospital of Philadelphia (CHOP).
January 31, 2022
/PRNewswire/ -- Fusion oncogenes, such as RET- and NTRK-gene fusions, are associated with more invasive pediatric thyroid cancers, correlating with the highest...
January 28, 2022
Fusion oncogenes, such as RET- and NTRK-gene fusions, are associated with more invasive pediatric thyroid cancers, correlating with the highest risk
January 26, 2022
A new diagnostic test has been designed to detect single nucleotide variants as well as large-scale deletions in the mitochondrial genome.
January 26, 2022
A new diagnostic test has been designed to detect single nucleotide variants as well as large-scale deletions in the mitochondrial genome.
January 25, 2022
Researchers from the Mitochondrial Medicine Frontier Program at Childrenโs Hospital of Philadelphia (CHOP) have developed a comprehensive sequencing
February 14, 2021
Share this article Share this article SHERIDAN, Wyo., Feb. 13, 2021 /PRNewswire/ -- WellAI data scientists Sergei Polevikov and Daniel Satchkov are to present their COVID-19 research based on an advanced machine learning technology at the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) annual conference on February 15, 2021.ย The title of their talk is "Comprehending Hundreds of Thousands of COVID-19 Studies using Mathematical Models of Language and AI". The WellA...
January 15, 2021
CHOP Researchers Find NTRK Fusions More Common than Expected in Pediatric Tumors --Study highlights wide range of pediatric cancers in which NTRK fusions are more likely to occur, which could help prioritize testing for targeted treatment with FDA-approved TRK inhibitors-- News provided by Share this article Share this article PHILADELPHIA, Jan. 15, 2021 /PRNewswire/ --ย In a large study of pediatric cancer patients, researchers from Childrens Hospital of Philadelphia (CHOP) have analyzed the f...